Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
- PMID: 35310621
- PMCID: PMC8927799
- DOI: 10.1093/ve/veac002
Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
Abstract
Transmission chains within small urban areas (accommodating ∼30 per cent of the European population) greatly contribute to case burden and economic impact during the ongoing coronavirus pandemic and should be a focus for preventive measures to achieve containment. Here, at very high spatio-temporal resolution, we analysed determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in a European urban area, Basel-City (Switzerland). We combined detailed epidemiological, intra-city mobility and socio-economic data sets with whole-genome sequencing during the first SARS-CoV-2 wave. For this, we succeeded in sequencing 44 per cent of all reported cases from Basel-City and performed phylogenetic clustering and compartmental modelling based on the dominating viral variant (B.1-C15324T; 60 per cent of cases) to identify drivers and patterns of transmission. Based on these results we simulated vaccination scenarios and corresponding healthcare system burden (intensive care unit (ICU) occupancy). Transmissions were driven by socio-economically weaker and highly mobile population groups with mostly cryptic transmissions which lacked genetic and identifiable epidemiological links. Amongst more senior population transmission was clustered. Simulated vaccination scenarios assuming 60-90 per cent transmission reduction and 70-90 per cent reduction of severe cases showed that prioritising mobile, socio-economically weaker populations for vaccination would effectively reduce case numbers. However, long-term ICU occupation would also be effectively reduced if senior population groups were prioritised, provided there were no changes in testing and prevention strategies. Reducing SARS-CoV-2 transmission through vaccination strongly depends on the efficacy of the deployed vaccine. A combined strategy of protecting risk groups by extensive testing coupled with vaccination of the drivers of transmission (i.e. highly mobile groups) would be most effective at reducing the spread of SARS-CoV-2 within an urban area.
© The Author(s) 2022. Published by Oxford University Press.
Figures





Similar articles
-
Long, thin transmission chains of Severe Acute Respiratory Syndrome Coronavirus 2 may go undetected for several weeks at low to moderate reproduction numbers: Implications for containment and elimination strategy.Infect Dis Model. 2021;6:474-489. doi: 10.1016/j.idm.2021.02.002. Epub 2021 Feb 23. Infect Dis Model. 2021. PMID: 33644500 Free PMC article.
-
Whole-genome Sequencing to Track Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Nosocomial Outbreaks.Clin Infect Dis. 2021 Jun 1;72(11):e727-e735. doi: 10.1093/cid/ciaa1433. Clin Infect Dis. 2021. PMID: 32954414 Free PMC article.
-
At-home testing to mitigate community transmission of SARS-CoV-2: protocol for a public health intervention with a nested prospective cohort study.BMC Public Health. 2021 Dec 4;21(1):2209. doi: 10.1186/s12889-021-12007-w. BMC Public Health. 2021. PMID: 34863144 Free PMC article. Clinical Trial.
-
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949. Cells. 2021. PMID: 34831172 Free PMC article. Review.
-
The Potential Role of Super Spread Events in SARS-COV-2 Pandemic; a Narrative Review.Arch Acad Emerg Med. 2020 Sep 21;8(1):e74. eCollection 2020. Arch Acad Emerg Med. 2020. PMID: 33134970 Free PMC article. Review.
Cited by
-
Detection of SARS-CoV-2 infection clusters: The useful combination of spatiotemporal clustering and genomic analyses.Front Public Health. 2022 Dec 1;10:1016169. doi: 10.3389/fpubh.2022.1016169. eCollection 2022. Front Public Health. 2022. PMID: 36568782 Free PMC article.
-
Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.Syst Rev. 2024 Jan 16;13(1):30. doi: 10.1186/s13643-023-02411-1. Syst Rev. 2024. PMID: 38229123 Free PMC article.
-
Vaccination passports: Challenges for a future of air transportation.Transp Policy (Oxf). 2021 Sep;110:394-401. doi: 10.1016/j.tranpol.2021.06.018. Epub 2021 Jun 29. Transp Policy (Oxf). 2021. PMID: 34608363 Free PMC article.
-
Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review.BMC Med. 2021 Dec 1;19(1):318. doi: 10.1186/s12916-021-02190-3. BMC Med. 2021. PMID: 34847950 Free PMC article. Review.
-
Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies.Res Pract Thromb Haemost. 2023 May;7(4):100182. doi: 10.1016/j.rpth.2023.100182. Epub 2023 May 18. Res Pract Thromb Haemost. 2023. PMID: 37333991 Free PMC article.
References
-
- AstraZeneca (2020), ‘AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19’.
-
- Bau- und Verkehrsdepartement Basel-Stadt Mobilität / Mobilitätsstrategie (2020), ‘Gesamtverkehrsmodell der Region Basel, Basismodell: “Ist-Zustand 2016”’.
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous